FDA WARNING_LETTER - Vidaslim Co. - December 20, 2024

The FDA issued a Warning Letter to Vidaslim Co. on July 17, 2025, following an inspection from December 9-20, 2024, at its San Antonio, Texas facility. The inspection revealed significant violations causing the company"s dietary supplements to be both adulterated and misbranded. Under the regulatory framework of 21 CFR Part 111, governing Current Good Manufacturing Practice for dietary supplements, Vidaslim Co. failed to establish and adhere to critical written procedures for quality control operations, including material review, product release, holding and distribution, reserve sample collection, management of received products, complaint investigations, handling of returned products, and packaging and labeling. The company also lacked proper records for product distribution. Additionally, several Vidaslim products, such as "Gut Check Probiotic Super Greens" and "Flaca ACV Gummies," were deemed misbranded under Section 403 of the Federal Food, Drug, and Cosmetic Act. Misbranding issues included the absence of a domestic address or phone number for adverse event reporting, failure to declare all common ingredient names, and incomplete listing of dietary ingredients with their quantities in the Supplement Facts labels. Vidaslim Co. had submitted responses, but the FDA found these insufficient, noting that corrective actions were either still in progress, lacked full implementation, or were inadequately described for evaluation. The FDA requires full implementation of all proposed procedures and a comprehensive correction of all identified violations to avoid further enforcement actions.